| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Miha Kotnik | |
| Tom Solmajer | |||
| Marko Oblak | |||
| P433 | issue | 19 | |
| P304 | page(s) | 2033-2047 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Current Medicinal Chemistry | Q3007710 |
| P1476 | title | Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents | |
| P478 | volume | 14 |
| Q33796345 | A high-throughput fluorescence polarization assay for inhibitors of gyrase B |
| Q35791501 | Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target |
| Q37998090 | Bacterial DNA replication enzymes as targets for antibacterial drug discovery |
| Q33398170 | Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue |
| Q33793074 | Challenges of antibacterial discovery |
| Q28284744 | DNA topoisomerases and their poisoning by anticancer and antibacterial drugs |
| Q35815665 | Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors |
| Q34095957 | Evaluating the genotoxicity of topoisomerase-targeted antibiotics |
| Q43473553 | Evaluation of WO2012177707 and WO2012097269: Vertex's phosphate prodrugs of gyrase and topoisomerase antibacterial agents |
| Q34214929 | Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. |
| Q93083428 | Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes |
| Q37694351 | In front of and behind the replication fork: bacterial type IIA topoisomerases. |
| Q54358881 | Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics. |
| Q94548290 | Lead Identification of 8-(Methylamino)-2-oxo-1,2-dihydroquinoline Derivatives as DNA Gyrase Inhibitors: Hit-to-Lead Generation Involving Thermodynamic Evaluation |
| Q42947154 | Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB. |
| Q38068475 | Multitarget ligands in antibacterial research: progress and opportunities |
| Q57265865 | New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity |
| Q42249570 | Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR. |
| Q51713941 | Quantitative structure-activity relationship study of antitubercular fluoroquinolones. |
| Q82816075 | Schiff bases of indoline-2,3-dione: potential novel inhibitors of Mycobacterium tuberculosis (Mtb) DNA gyrase |
| Q27675559 | Structural–Functional Studies of Burkholderia cenocepacia d -Glycero-β- d -manno-heptose 7-Phosphate Kinase (HldA) and Characterization of Inhibitors with Antibiotic Adjuvant and Antivirulence Properties |
| Q48175813 | Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors |
| Q37612256 | Syringa oblata Lindl. Aqueous Extract Is a Potential Biofilm Inhibitor in S. suis |
| Q35872631 | Targeting druggable enzymome by exploiting natural medicines: An in silico-in vitro integrated approach to combating multidrug resistance in bacterial infection |
| Q43221173 | The challenge of developing robust drugs to overcome resistance |
| Q45717201 | Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli |
| Q28538023 | Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents |
| Q42710319 | Tricyclic sesquiterpenes from Vetiveria zizanoides (L.) Nash as antimycobacterial agents |
Search more.